Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
University Hospital, Clermont-Ferrand
AstraZeneca
Context Therapeutics Inc.
Indiana University
BioNTech SE
Memorial Sloan Kettering Cancer Center
Loma Linda University
City of Hope Medical Center
University of Nebraska
Vastra Gotaland Region
Cantonal Hospital of St. Gallen
University Medical Center Groningen
University of Southern California
West China Hospital
Massive Bio, Inc.
University of Arizona
Jonsson Comprehensive Cancer Center
Western University, Canada
Jagiellonian University
Columbia University
University Medical Center Groningen
University of California, Irvine
University Health Network, Toronto